thiodigalactoside has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, H; Bum-Erdene, K; Collins, PM; Fei, F; Grice, ID; Groffen, J; Heisterkamp, N; Hugo, MW; Kishor, C; Leffler, H; Nilsson, UJ; Tarighat, SS | 1 |
1 other study(ies) available for thiodigalactoside and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
Topics: Antineoplastic Agents; Binding Sites; Drug Design; Galectin 3; Humans; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2022 |